Gulf Pharmaceutical Industries

JULPHARStocksAbu Dhabi Securities ExchangeHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (AED)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.08B	1.31B	1.28B	1.62B	1.14B
Cost of Revenue	0.64B	0.79B	0.85B	1.06B	0.76B
Gross Profit	435.90M	519.10M	425.10M	557.90M	383.40M
SG&A	358.70M	454.50M	458.30M	596.30M	451.90M
R&D	28.20M	—	—	—	—
Operating Expenses	372.20M	444.10M	449.60M	586.50M	341.90M
Operating Income	63.70M	75.00M	-24.50M	-28.60M	41.50M
Interest Income	7.60M	2.60M	6.00M	3.60M	2.40M
Interest Expense	-28.30M	-62.20M	-56.30M	-40.10M	-23.70M
Pretax Income	47.40M	20.00M	-69.80M	-33.40M	42.60M
Income Tax	3.50M	3.70M	6.10M	2.80M	1.10M
Net Income	172.20M	44.60M	-99.10M	-29.40M	64.40M
EBITDA	107.70M	167.20M	74.90M	66.50M	128.50M
EBIT	63.70M	75.00M	-24.50M	-28.60M	41.50M
EPS (Basic)	0.15	0.04	-0.09	-0.03	0.06
EPS (Diluted)	0.15	0.04	-0.09	-0.03	0.06
Margins & Efficiency
Gross Margin %	+40.5%	+39.6%	+33.3%	+34.5%	+33.5%
EBITDA Margin %	+10.0%	+12.7%	+5.9%	+4.1%	+11.2%
Net Margin %	+16.0%	+3.4%	-7.8%	-1.8%	+5.6%
Revenue & Income
Revenue	1.08B	1.31B	1.28B	1.62B	1.14B
Revenue Growth (YoY)	-18.1%	+2.7%	-21.0%	+41.4%	+99.5%
Interest & Investment Income	7.60M	2.60M	6.00M	3.60M	2.40M
Earnings From Equity Investments	—	—	—	—	-31.40M
Gain (Loss) on Sale of Investments	4.40M	3.30M	3.50M	2.00M	-5.50M
Currency Exchange Gain (Loss)	—	700.00K	—	200.00K	—
Expenses & Provisions
Cost of Revenue	0.64B	0.79B	0.85B	1.06B	0.76B
Selling, General & Admin	358.70M	454.50M	458.30M	596.30M	451.90M
Research & Development	28.20M	—	—	—	—
Operating Expenses	372.20M	444.10M	449.60M	586.50M	341.90M
Other Operating Expenses	-14.70M	-10.40M	-8.70M	-9.80M	-110.00M
Interest Expense	-28.30M	-62.20M	-56.30M	-40.10M	-23.70M
Asset Writedown	—	-1.50M	—	—	—
D&A For EBITDA	44.00M	92.20M	99.40M	95.10M	87.00M
Profitability & Returns
Gross Profit	435.90M	519.10M	425.10M	557.90M	383.40M
Gross Margin	+40.5%	+39.6%	+33.3%	+34.5%	+33.5%
EBIT	63.70M	75.00M	-24.50M	-28.60M	41.50M
EBIT Margin	+5.9%	+5.7%	-1.9%	-1.8%	+3.6%
EBITDA	107.70M	167.20M	74.90M	66.50M	128.50M
EBITDA Margin	+10.0%	+12.7%	+5.9%	+4.1%	+11.2%
EBT Excluding Unusual Items	43.00M	16.10M	-74.80M	-64.90M	-11.20M
Pretax Income	47.40M	20.00M	-69.80M	-33.40M	42.60M
Operating Income	63.70M	75.00M	-24.50M	-28.60M	41.50M
Operating Margin	+5.9%	+5.7%	-1.9%	-1.8%	+3.6%
Profit Margin	+16.0%	+3.4%	-7.8%	-1.8%	+5.6%
Net Income	172.20M	44.60M	-99.10M	-29.40M	64.40M
Net Income to Common	172.20M	44.60M	-99.10M	-29.40M	64.40M
Net Income to Company	173.30M	44.90M	-98.50M	-31.70M	59.40M
Net Income Growth	+286.1%	—	—	—	—
Earnings From Continuing Ops.	43.90M	16.30M	-75.90M	-36.20M	41.50M
Earnings From Discontinued Ops.	129.40M	28.60M	-22.60M	4.50M	17.90M
Minority Interest in Earnings	-1.10M	-0.30M	-0.60M	2.30M	5.00M
Income Tax Expense	3.50M	3.70M	6.10M	2.80M	1.10M
Effective Tax Rate	+7.4%	+18.5%	—	—	+2.6%
Per Share & Capital
EPS (Basic)	0.15	0.04	-0.09	-0.03	0.06
EPS (Diluted)	0.15	0.04	-0.09	-0.03	0.06
EPS Growth	+286.2%	—	—	—	—
Shares Change (YoY)	-0	—	—	—	0.09
Shares Outstanding (Basic)	1.15B	1.16B	1.16B	1.16B	1.16B
Shares Outstanding (Diluted)	1.15B	1.16B	1.16B	1.16B	1.16B
Free Cash Flow	85.20M	201.30M	71.50M	-44.40M	1.80M
Free Cash Flow Margin	+7.9%	+15.3%	+5.6%	-2.7%	+0.2%
Free Cash Flow Per Share	0.07	0.17	0.06	-0.04	0.00
Supplemental
Other Unusual Items	—	2.10M	1.50M	29.50M	59.30M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (AED)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.08B	1.31B	1.28B	1.62B	1.14B
Cost of Revenue	0.64B	0.79B	0.85B	1.06B	0.76B
Gross Profit	435.90M	519.10M	425.10M	557.90M	383.40M
SG&A	358.70M	454.50M	458.30M	596.30M	451.90M
R&D	28.20M	—	—	—	—
Operating Expenses	372.20M	444.10M	449.60M	586.50M	341.90M
Operating Income	63.70M	75.00M	-24.50M	-28.60M	41.50M
Interest Income	7.60M	2.60M	6.00M	3.60M	2.40M
Interest Expense	-28.30M	-62.20M	-56.30M	-40.10M	-23.70M
Pretax Income	47.40M	20.00M	-69.80M	-33.40M	42.60M
Income Tax	3.50M	3.70M	6.10M	2.80M	1.10M
Net Income	172.20M	44.60M	-99.10M	-29.40M	64.40M
EBITDA	107.70M	167.20M	74.90M	66.50M	128.50M
EBIT	63.70M	75.00M	-24.50M	-28.60M	41.50M
EPS (Basic)	0.15	0.04	-0.09	-0.03	0.06
EPS (Diluted)	0.15	0.04	-0.09	-0.03	0.06
Margins & Efficiency
Gross Margin %	+40.5%	+39.6%	+33.3%	+34.5%	+33.5%
EBITDA Margin %	+10.0%	+12.7%	+5.9%	+4.1%	+11.2%
Net Margin %	+16.0%	+3.4%	-7.8%	-1.8%	+5.6%
Revenue & Income
Revenue	1.08B	1.31B	1.28B	1.62B	1.14B
Revenue Growth (YoY)	-18.1%	+2.7%	-21.0%	+41.4%	+99.5%
Interest & Investment Income	7.60M	2.60M	6.00M	3.60M	2.40M
Earnings From Equity Investments	—	—	—	—	-31.40M
Gain (Loss) on Sale of Investments	4.40M	3.30M	3.50M	2.00M	-5.50M
Currency Exchange Gain (Loss)	—	700.00K	—	200.00K	—
Expenses & Provisions
Cost of Revenue	0.64B	0.79B	0.85B	1.06B	0.76B
Selling, General & Admin	358.70M	454.50M	458.30M	596.30M	451.90M
Research & Development	28.20M	—	—	—	—
Operating Expenses	372.20M	444.10M	449.60M	586.50M	341.90M
Other Operating Expenses	-14.70M	-10.40M	-8.70M	-9.80M	-110.00M
Interest Expense	-28.30M	-62.20M	-56.30M	-40.10M	-23.70M
Asset Writedown	—	-1.50M	—	—	—
D&A For EBITDA	44.00M	92.20M	99.40M	95.10M	87.00M
Profitability & Returns
Gross Profit	435.90M	519.10M	425.10M	557.90M	383.40M
Gross Margin	+40.5%	+39.6%	+33.3%	+34.5%	+33.5%
EBIT	63.70M	75.00M	-24.50M	-28.60M	41.50M
EBIT Margin	+5.9%	+5.7%	-1.9%	-1.8%	+3.6%
EBITDA	107.70M	167.20M	74.90M	66.50M	128.50M
EBITDA Margin	+10.0%	+12.7%	+5.9%	+4.1%	+11.2%
EBT Excluding Unusual Items	43.00M	16.10M	-74.80M	-64.90M	-11.20M
Pretax Income	47.40M	20.00M	-69.80M	-33.40M	42.60M
Operating Income	63.70M	75.00M	-24.50M	-28.60M	41.50M
Operating Margin	+5.9%	+5.7%	-1.9%	-1.8%	+3.6%
Profit Margin	+16.0%	+3.4%	-7.8%	-1.8%	+5.6%
Net Income	172.20M	44.60M	-99.10M	-29.40M	64.40M
Net Income to Common	172.20M	44.60M	-99.10M	-29.40M	64.40M
Net Income to Company	173.30M	44.90M	-98.50M	-31.70M	59.40M
Net Income Growth	+286.1%	—	—	—	—
Earnings From Continuing Ops.	43.90M	16.30M	-75.90M	-36.20M	41.50M
Earnings From Discontinued Ops.	129.40M	28.60M	-22.60M	4.50M	17.90M
Minority Interest in Earnings	-1.10M	-0.30M	-0.60M	2.30M	5.00M
Income Tax Expense	3.50M	3.70M	6.10M	2.80M	1.10M
Effective Tax Rate	+7.4%	+18.5%	—	—	+2.6%
Per Share & Capital
EPS (Basic)	0.15	0.04	-0.09	-0.03	0.06
EPS (Diluted)	0.15	0.04	-0.09	-0.03	0.06
EPS Growth	+286.2%	—	—	—	—
Shares Change (YoY)	-0	—	—	—	0.09
Shares Outstanding (Basic)	1.15B	1.16B	1.16B	1.16B	1.16B
Shares Outstanding (Diluted)	1.15B	1.16B	1.16B	1.16B	1.16B
Free Cash Flow	85.20M	201.30M	71.50M	-44.40M	1.80M
Free Cash Flow Margin	+7.9%	+15.3%	+5.6%	-2.7%	+0.2%
Free Cash Flow Per Share	0.07	0.17	0.06	-0.04	0.00
Supplemental
Other Unusual Items	—	2.10M	1.50M	29.50M	59.30M